Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
18.82
+0.42 (2.26%)
Jan 21, 2026, 11:51 AM EST - Market open
Evommune Market Cap
Evommune has a market cap or net worth of $593.13 million as of January 21, 2026.
Market Cap
593.13M
Enterprise Value
504.75M
1-Year Change
n/a
Ranking
Category
Stock Price
18.82
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $593.13M, an increase of 23.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 580.04M | 7.48% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |